Happy Bobby Bonilla Day to those who celebrate. For the 16th straight year, the Mets are paying Bonilla $1.19 million on July 1 due to one of the most bizarre deals in sports history. After Bonilla, ...

CASCADE, Colo. (KOAA) — There is an electric-powered addition to the fleet of patrol vehicles on Pikes Peak. E-bikes are the newest tool for rangers working on the north slope of Pikes Peak, changing ...

The A's will be adding some depth to their minor league system, as they have elected to sign right-hander Andrew Bash to a minor league contract. The 29-year-old will join the A's Triple-A squad, the ...

Browse projects, edit plans, run simulations, load flood results, extract flow hydrographs, and animate time steps — all inside QGIS, without opening HEC-RAS.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lizzo’s new album Bitch arrives as a major commercial disappointment, debuting on just one ...

Add Yahoo as a preferred source to see more of our stories on Google. Image via Shutterstock/Paul Juser The bond between pets and their humans is unlike anything else, which is why one cat's final ...

The bond between pets and their humans is unlike anything else, which is why one cat's final gesture is touching so many hearts. In recent months, TikTok users have been sharing emotional videos as ...

Editor's note: Follow live updates from NCAA baseball Super Regionals with USA TODAY Sports' daily live scoreboard. NCAA baseball tournament continues this weekend with super regionals at eight sites.

Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.